Jiangsu GDK Biotechnology Co Ltd (688670) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.038x

Based on the latest financial reports, Jiangsu GDK Biotechnology Co Ltd (688670) has a cash flow conversion efficiency ratio of -0.038x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-44.96 Million ≈ $-6.58 Million USD) by net assets (CN¥1.19 Billion ≈ $174.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Jiangsu GDK Biotechnology Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

Jiangsu GDK Biotechnology Co Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Jiangsu GDK Biotechnology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jiangsu GDK Biotechnology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangsu GDK Biotechnology Co Ltd ranked by their cash flow conversion efficiency. Explore Jiangsu GDK Biotechnology Co Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Platinum Capital Ltd AU:PMC	0.029x
Career Technology MFG Co Ltd TW:6153	-0.028x
Nordic Paper Holding AB ST:NPAPER	0.115x
Beijing Seeyon Internet Software Cp SHG:688369	-0.118x
InPlay Oil Corp TO:IPO	0.076x
Dhani Services Limited NSE:DHANI	0.010x
Century Therapeutics Inc NASDAQ:IPSC	-0.085x
SMS Electric Co Ltd Zhengzhou SHE:002857	-0.037x

Annual Cash Flow Conversion Efficiency for Jiangsu GDK Biotechnology Co Ltd (2017–2025)

The table below shows the annual cash flow conversion efficiency of Jiangsu GDK Biotechnology Co Ltd from 2017 to 2025. View latest Jiangsu GDK Biotechnology Co Ltd stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.10 Billion ≈ $160.83 Million	CN¥-166.45 Million ≈ $-24.36 Million	-0.151x	-47.26%
2024-12-31	CN¥1.28 Billion ≈ $186.95 Million	CN¥-131.39 Million ≈ $-19.23 Million	-0.103x	-274.28%
2023-12-31	CN¥1.37 Billion ≈ $200.63 Million	CN¥80.90 Million ≈ $11.84 Million	0.059x	+123.17%
2022-12-31	CN¥1.46 Billion ≈ $213.60 Million	CN¥38.60 Million ≈ $5.65 Million	0.026x	-62.82%
2021-12-31	CN¥1.46 Billion ≈ $213.84 Million	CN¥103.93 Million ≈ $15.21 Million	0.071x	-84.24%
2020-12-31	CN¥242.50 Million ≈ $35.49 Million	CN¥109.46 Million ≈ $16.02 Million	0.451x	-9.49%
2019-12-31	CN¥-108.38 Million ≈ $-15.86 Million	CN¥-54.05 Million ≈ $-7.91 Million	0.499x	+25.58%
2018-12-31	CN¥-89.34 Million ≈ $-13.07 Million	CN¥-35.48 Million ≈ $-5.19 Million	0.397x	-26.73%
2017-12-31	CN¥-61.33 Million ≈ $-8.97 Million	CN¥-33.24 Million ≈ $-4.86 Million	0.542x	--

About Jiangsu GDK Biotechnology Co Ltd

SHG:688670 China Biotechnology

Market Cap

$342.53 Million

CN¥2.34 Billion CNY

Market Cap Rank

#14348 Global

#4316 in China

Share Price

CN¥19.00

Change (1 day)

+2.43%

52-Week Range

CN¥12.97 - CN¥30.90

All Time High

CN¥75.07